Hottest Stocks
(Over $10)		 Hottest Stocks
($2-$10)		 Biggest Losers
(Over $10)		 Biggest Losers
($2-$10)		 Hottest
Industries		 Hottest
Sectors		 EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Avantor, Inc. (AVTR : NYSE)
 
 • Company Description   
Avantor Inc. is a provider of critical products and services primarily to biopharma, healthcare, education & government, advanced technologies & applied materials industries. Avantor Inc. is based in Radnor, United States.

Number of Employees: 13,500

 
 • Price / Volume Information   
Yesterday's Closing Price: $13.46 Daily Weekly Monthly
20 Day Moving Average: 11,441,076 shares
Shares Outstanding: 681.43 (millions)
Market Capitalization: $9,172.04 (millions)
Beta: 1.05
52 Week High: $28.00
52 Week Low: $11.82
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week 3.86% -0.64%
12 Week -11.62% -27.90%
Year To Date -36.12% -39.45%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
BUILDING ONE SUITE 200 100 MATSONFORD ROAD
-
RADNOR,PA 19087
USA		 ph: 610-386-1700
fax: -		 avantorir@avantorsciences.com http://www.avantorsciences.com
 
 • General Corporate Information   
Officers
Jonathan Peacock - Chairman of the Board
R. Brent Jones - Chief Financial Officer
Steven Eck - Chief Accounting Officer
John Carethers - Director
Lan Kang - Director

Peer Information
Avantor, Inc. (CHCR)
Avantor, Inc. (ESRX)
Avantor, Inc. (MYDP)
Avantor, Inc. (COR)
Avantor, Inc. (GBCS)
Avantor, Inc. (LAXAF)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: Medical Services
Sector: Medical
CUSIP: 05352A100
SIC: 3826
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/25
Next Expected EPS Date: 08/01/25
Share - Related Items
Shares Outstanding: 681.43
Most Recent Split Date: (:1)
Beta: 1.05
Market Capitalization: $9,172.04 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $0.25 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $1.03 Payout Ratio: 0.00
Number of Estimates in the Fiscal Year Consensus: 9.00 Change In Payout Ratio: 0.00
Estmated Long-Term EPS Growth Rate: 9.14% Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/01/25  
 

 • Fundamental Ratios
P/E
Current FY Estimate: 13.06
Trailing 12 Months: 13.33
PEG Ratio: 1.43
Price Ratios
Price/Book: 1.50
Price/Cash Flow: 8.37
Price / Sales: 1.37
EPS Growth
vs. Year Ago Period: 4.55%
vs. Previous Quarter: -14.81%
Sales Growth
vs. Year Ago Period: -5.86%
vs. Previous Quarter: -6.24%
ROE
06/30/25 - -
03/31/25 - 11.93
12/31/24 - 12.17
ROA
06/30/25 - -
03/31/25 - 5.50
12/31/24 - 5.38
Current Ratio
06/30/25 - -
03/31/25 - 1.12
12/31/24 - 1.07
Quick Ratio
06/30/25 - -
03/31/25 - 0.75
12/31/24 - 0.70
Operating Margin
06/30/25 - -
03/31/25 - 10.28
12/31/24 - 9.99
Net Margin
06/30/25 - -
03/31/25 - 10.70
12/31/24 - 10.49
Pre-Tax Margin
06/30/25 - -
03/31/25 - 12.85
12/31/24 - 12.59
Book Value
06/30/25 - -
03/31/25 - 8.95
12/31/24 - 8.75
Inventory Turnover
06/30/25 - -
03/31/25 - 5.81
12/31/24 - 5.78
Debt-to-Equity
06/30/25 - -
03/31/25 - 0.54
12/31/24 - 0.54
Debt-to-Capital
06/30/25 - -
03/31/25 - 34.97
12/31/24 - 35.19
 

Powered by Zacks Investment Research ©